The landscape of India’s Media & Entertainment (M&E) industry has been transforming rapidly. Riding the wave of exponential progress made towards digital accessibility and adoption, the M&E industry has been a harbinger of a dynamic and aspirational India. Times...
The Mineral Laws (Amendment) Ordinance 2020 was approved to be promulgated by the Union Cabinet on January 10, 2020. The ordinance introduced amendments in the Mines and Minerals (Development and Regulation) (MMDR) Act, 1957 and the Coal Mines (Special...
The US$ 38 billion Indian pharmaceutical industry has played a pivotal role in ensuring access to innovative new therapies for patients in the country while helping develop India as a destination of global manufacturing and a source for quality...
Over the past week, terms like ‘social distancing’ and ‘self -quarantine’ have become common parlance. Apprehension is escalating about COVID 19 and mandates to cancel events, work from home, schools being closed, staying away from congregations and so on,...
India has an established domestic pharmaceutical industry, with a strong network of 3,000 drug companies and about 10,500 manufacturing units which provides us immense opportunities in many different areas including export, contract manufacturing, outsourced clinical trials and innovative research...
On January 10, 2020 the Mineral Laws (Amendment) Ordinance, 2020 was promulgated by the Union Cabinet. The Ordinance amends the Mines and Minerals (Development and Regulation) Act, 1957 (MMDR Act) and the Coal Mines (Special Provisions) Act, 2015 (CMSP Act)....